Jeffrey H Cooper Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey H Cooper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey H Cooper. Jeffrey H Cooper is SVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN).
Latest Insider Trading Transactions of Jeffrey H Cooper
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 3,750 | 53,963 | 153,792 | |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 21.51 | 6,500 | 139,815 | 157,542 | |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 26.49 | 15,000 | 397,350 | 164,042 | |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 38.09 | 25,250 | 961,717 | 41,089 | 66.3 K to 41.1 K (-38.06 %) |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 14.39 | 3,750 | 53,963 | 66,339 | 62.6 K to 66.3 K (+5.99 %) |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 21.51 | 6,500 | 139,815 | 62,589 | 56.1 K to 62.6 K (+11.59 %) |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 26.49 | 15,000 | 397,350 | 56,089 | 41.1 K to 56.1 K (+36.51 %) |
May 16 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 19.35 | 985 | 19,056 | 41,089 | 40.1 K to 41.1 K (+2.46 %) |
Jun 09 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
Jun 09 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 0.00 | 2,000 | 0 | 39,876 | 37.9 K to 39.9 K (+5.28 %) |
May 24 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
May 24 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 0.00 | 2,000 | 0 | 37,876 | 35.9 K to 37.9 K (+5.57 %) |
May 16 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | A | 26.49 | 60,000 | 1,589,400 | 362,750 | |
May 16 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 0.00 | 7,500 | 0 | 35,876 | 28.4 K to 35.9 K (+26.43 %) |
May 16 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 11.64 | 1,566 | 18,223 | 28,376 | 26.8 K to 28.4 K (+5.84 %) |
Oct 27 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 6.13 | 13,750 | 84,288 | 342,750 | |
Oct 27 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 5.15 | 1,459 | 7,514 | 356,500 | |
Oct 27 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 24.00 | 15,209 | 365,016 | 26,486 | 41.7 K to 26.5 K (-36.48 %) |
Oct 27 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 6.13 | 13,750 | 84,288 | 41,695 | 27.9 K to 41.7 K (+49.20 %) |
Oct 27 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 5.15 | 1,459 | 7,514 | 27,945 | 26.5 K to 27.9 K (+5.51 %) |
Sep 15 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 22.85 | 6,000 | 137,106 | 26,486 | 32.5 K to 26.5 K (-18.47 %) |
Jun 08 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 2,000 | 0 | 6,000 | |
Jun 08 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 2,000 | 0 | 8,000 | |
Jun 08 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 0.00 | 2,000 | 0 | 32,486 | 30.5 K to 32.5 K (+6.56 %) |
Jun 08 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 0.00 | 2,000 | 0 | 30,486 | 28.5 K to 30.5 K (+7.02 %) |
May 14 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | A | 21.51 | 63,000 | 1,355,130 | 357,959 | |
May 14 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 0.00 | 8,400 | 0 | 28,486 | 20.1 K to 28.5 K (+41.82 %) |
May 14 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 11.64 | 1,502 | 17,478 | 20,086 | 18.6 K to 20.1 K (+8.08 %) |
Page: 1